作者: Neeltje Kootstra , Reindert P van Steenwijk , Marc van der Valk , M Bradley Drummond , Gregory D Kirk
DOI: 10.1016/S2666-7568(21)00033-7
关键词: FEV1/FVC ratio 、 Human immunodeficiency virus (HIV) 、 Spirometry 、 Vital capacity 、 Internal medicine 、 Medicine 、 Prospective cohort study 、 Cohort study 、 Lung function 、 Cohort
摘要: Summary Background The AGEhIV cohort study is a prospective evaluating the occurrence of age-related comorbidities in people living with and without HIV. We previously reported lower forced vital capacity (FVC) HIV-positive compared HIV-negative participants those heavy smoking exposure at time enrolment study. In this we evaluate longitudinal changes spirometry indices same accounting for behaviour other risk factors. Methods obtained pre-bronchodilator measurements during biennial visits over median 5·9 years (IQR 5·7–6·0). Adjusted declines expiratory volume 1 s (FEV1), FVC, FEV1/FVC ratio were modelled using linear mixed-effects models by HIV status status. To whether could be driven increased levels chronic inflammation, assessed associations between rates FEV1 FVC decline CD4 CD8 T-cell counts, plasma concentrations C-reactive protein (CRP), interleukin 6, soluble CD14, CD163, intestinal fatty-acid-binding separate models. registered ClinicalTrials.gov , NCT01466582 . Findings 500 481 included data from Oct 29, 2010, to Aug 14, 2018. virally suppressed ( Interpretation Treated infection was associated faster both but not ratio. These independent might have been ongoing interstitial or small airway damage, potentially related inflammation. Funding ZonMW, Aidsfonds, Gilead Sciences, ViiV Healthcare, Janssen Pharmaceuticals, Merck.